The FDA NEEDS this to work. Seriously, people at BARDA are getting fired for pointing out that Hydroxychloroquine doesn't work. I can see those FDA doors swinging WIDE open for SI and Co. when they next come round for a visit to discuss Ryoncil and the status of that little trial going on around the traps...
I have no doubt that the FDA was well aware of this announcement and it was vetted by them to ensure no lines were crossed. This is literally the first solid ray of treatment sunshine (if a ray can be solid...) throughout this entire mess. FFS, the moron in chief is so desperate he is touting injections of disinfectant...
I can imagine there are a number of FDA employees breathing an absolute sigh of relief that MSB has popped up with what appears to be a science-based silver bullet, just when all of the villagers are getting dragged away by that pesky werewolf!
As the hero of our tale, I hope the FDA rewards SI richly, showering him with immediate approvals for Ryconcil for AGVHD, Remestemcel for ARDS, off-label use for Ryoncil for other conditions, and all of the other treatments we have in the pipeline.
The sweetness of it, too, is the scale of the pandemic will mean EVERYONE who has been calling stem cell treatment crap (usually in defence of their own miracle elixir) are going to be shouted down by people who just want what is PROVEN to work. Money talks, B.S. walks.
- Forums
- ASX - By Stock
- MSB
- Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-261
-
- There are more pages in this discussion • 587 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
96.0¢ |
Change
0.010(1.05%) |
Mkt cap ! $1.101B |
Open | High | Low | Value | Volume |
94.5¢ | 97.5¢ | 94.0¢ | $2.076M | 2.161M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 162826 | 96.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.0¢ | 28820 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 162826 | 0.960 |
6 | 80489 | 0.955 |
6 | 62777 | 0.950 |
1 | 5500 | 0.945 |
9 | 112571 | 0.940 |
Price($) | Vol. | No. |
---|---|---|
0.970 | 28820 | 3 |
0.975 | 27691 | 4 |
0.980 | 60702 | 4 |
0.985 | 70702 | 3 |
0.990 | 93055 | 5 |
Last trade - 16.10pm 21/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online